Suggest one concentrate more and more on large caps (Nifty 50) in Pharma Sector which remained grounded for quite some time but they seem to be providing good opportunity at current level.
DRL is one such stock with fantastic market exposure and respectable price to earning. Good BV at more than 600 and a totally debt free company with growing reserves to the tune of around 10000 as per the last data available. Dividend of 400% on FV of Rs.5/- is another positive factor which makes this stock to be more attractive.
And add to it Promoters and foreign institutions holding around 78% of total shares with Other FIs and NBFC with rest of the shares. Even CRR - DPR with ratio of 84 : 16 is investor friendly. Buying at current price of 3100 is likely to make for 3500 for those who hold patience. In any case, it makes a defensive stock too in volatile market conditions.